Clinical Trial Update: A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the efficacy of JNJ-89495120 for Major depressive disorder; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• JNJ-89495120

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 2 | Status: RECRUITING